PBM fitness as vehicle for disease management initiatives remains open question, FTC official says.
Executive Summary
PBM FITNESS FOR DISEASE MANAGEMENT QUESTIONED BY FTC OFFICIAL at a Food & Drug Law Institute conference in Washington, D.C. Sept. 4. While disease management "seems like an initiative that pharmaceutical companies are very well suited for, the question we've always had and still have is whether [pharmacy benefit managers] are really the right vehicle" for the initiative, Federal Trade Commission Bureau of Competition Assistant Director Michael McNeely said.